logo

For the Inventor, By the Inventor

Roslyn, PA, United States of America

Robert J Suhadolnik

USPTO Granted Patents = 18


Average Co-Inventor Count = 1.8

ph-index = 8

Forward Citations = 1,572(Granted Patents)


Company Filing History:

goldMedal15 out of 412 
 
Temple University
 patents
silverMedal3 out of 444 
 
Research, Incorporated
 patents

Years Active: 1984-2002

Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents
1. 6362171 - Aminoaklanoyl-linked conjugates of 2′,5′-oligoadenylate and antiviral uses thereof (2002-03-26),
2. 6281201 - Base-modified derivatives of 2′,5′-oligoadenylate and antiviral uses thereof (2001-08-28),
3. 6214554 - Chronic fatigue syndrome diagnosis (2001-04-10),
4. 6207366 - Chronic fatigue syndrome diagnosis (2001-03-27),
5. 5985565 - Chronic fatigue syndrome diagnosis (1999-11-16),
6. 5863905 - 2',5'-phosphorothioate/phosphodiester oligoadenylates and anti-viral (1999-01-26),
7. 5700785 - 3'-deoxy or 3'-O-substituted-2',5'-oligoadenylates as antiviral agents (1997-12-23),
8. 5643889 - Cholesterol conjugates of 2'5'-oligoadenylate derivatives and antiviral (1997-07-01),
9. 5556840 - 2',5'-phosphorothioate oligoadenylates as anitiviral agents (1996-09-17),
10. 5550111 - Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof (1996-08-27),
11. 5405939 - 2',5'-phosphorothioate oligoadenylates and their covalent conjugates (1995-04-11),
12. 5188897 - Encapsulated 2',5'-phosphorothioate oligoadenylates (1993-02-23),
13. 4990498 - 2- and 8-azido(2'-5')oligoadenylates and antiviral uses thereof (1991-02-05),
14. 4924624 - 2,',5'-phosphorothioate oligoadenylates and plant antiviral uses thereof (1990-05-15),
15. 4859768 - Derivatives of 2', 5'-oligoadenylate and antiviral uses thereof (1989-08-22),

Title: Spotlight on Inventor Robert J. Suhadolnik

Introduction: Robert J. Suhadolnik, a prolific inventor based in Roslyn, PA (US), has made significant contributions to the field of antiviral compounds with a total of 18 patents to his name.

Latest Patents: Among his latest patents is "Aminoaklanoyl-linked conjugates of 2′,5′-oligoadenylate and antiviral uses thereof," which showcases his innovative work in developing novel antiviral compounds with specific chemical formulas. Additionally, the patent for "Base-modified derivatives of 2′,5′-oligoadenylate and antiviral uses thereof" further underscores his expertise in this area.

Career Highlights: Robert J. Suhadolnik has worked with esteemed organizations such as Temple University of the Commonwealth System of Higher Education and Research, Incorporated, where he has undoubtedly honed his skills and knowledge in the field of antiviral research. His 18 patents serve as a testament to his dedication and expertise in developing cutting-edge solutions in the fight against viral infections.

Collaborations: Throughout his career, Robert J. Suhadolnik has collaborated with notable individuals in the industry, including Wolfgang Pfleiderer and Joseph M. Wu. These collaborations have likely played a crucial role in shaping his inventive work and driving innovation in antiviral research.

Conclusion: In conclusion, Robert J. Suhadolnik stands as a formidable figure in the realm of antiviral compounds, with a remarkable portfolio of 18 patents that highlight his ingenuity and commitment to advancing the field. His collaborations and career milestones further underscore his significant contributions to the scientific community, making him a respected figure in the world of innovation and inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…